Short Interest in Genenta Science S.p.A. (NASDAQ:GNTA) Experiences Significant Decline

In February, Genenta Science S.p.A. (NASDAQ:GNTA - Get Free Report) faced a notable drop in short interest. The short interest as of February 28 totaled 1,500 shares, reflecting a 40.0% decrease from the 2,500 shares reported on February 13. Currently, only 0.0% of the company’s shares are sold short. Given an average daily trading volume of 10,400 shares, the current short-interest ratio stands at just 0.1 days.

Institutional Investments in Genenta Science

Recently, a hedge fund made a new investment in Genenta Science. Citadel Advisors LLC acquired a stake in the company during the fourth quarter, as noted in their latest filing with the Securities and Exchange Commission (SEC). They acquired 11,167 shares valued at about $46,000. Following this purchase, Citadel Advisors LLC holds approximately 0.06% of Genenta Science. Overall, institutional investors and hedge funds collectively own around 15.13% of the shares.

Stock Performance of Genenta Science

On a recent trading day, GNTA stock saw a decrease of $0.11, bringing its price to $3.84. The trading volume reached 1,273 shares, which is less than the average volume of 8,263 shares. The stock exhibits a 50-day moving average of $4.07 and a 200-day moving average of $4.54. Over the past year, the stock has recorded a low of $2.20 and a high of $7.28.

Overview of Genenta Science

Genenta Science S.p.A. is a biotechnology company that is currently in the clinical stage. It focuses on developing hematopoietic stem cell gene therapies aimed at treating solid tumors in Italy. The leading product in its pipeline is Temferon, which is undergoing Phase 1/2a clinical trials for treating glioblastoma multiforme in patients with an unmethylated MGMT gene promoter.

Additional Insights

For those interested in investments, it’s worth noting that Genenta Science currently holds a Buy rating from analysts. However, top financial analysts have indicated that there are at least five other stocks they consider more favorable at this time. Investors may want to look into these options before making investment decisions.

short, interest, investment